Christophe Guignabert

Christophe Guignabert

UNVERIFIED PROFILE

Are you Christophe Guignabert?   Register this Author

Register author
Christophe Guignabert

Christophe Guignabert

Publications by authors named "Christophe Guignabert"

Are you Christophe Guignabert?   Register this Author

100Publications

9019Reads

30Profile Views

The Multiple Roles of Macrophage Migration Inhibitory Factor in Pulmonary Hypertension.

Am J Physiol Lung Cell Mol Physiol 2019 Oct 2. Epub 2019 Oct 2.

Cardiovascular research, INSERM UMR_S 999, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajplung.00234.2019DOI Listing
October 2019

Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".

Circ Res 2019 Apr;124(9):e82-e83

Université Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.119.315053DOI Listing
April 2019

Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets.

Drug Discov Today 2019 02 13;24(2):428-439. Epub 2018 Nov 13.

Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13596446183032
Publisher Site
http://dx.doi.org/10.1016/j.drudis.2018.11.003DOI Listing
February 2019

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.

Front Physiol 2018 10;9:1777. Epub 2018 Dec 10.

Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2018.01777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298242PMC
December 2018

Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension.

Chest 2018 10 22;154(4):872-881. Epub 2018 May 22.

Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France; Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2018.05.006DOI Listing
October 2018

[IL6R is the key therapeutical target in pulmonary arterial hypertension].

Med Sci (Paris) 2018 Oct 19;34(10):765-768. Epub 2018 Nov 19.

Inserm UMR_S 999, hôpital Marie Lannelongue, 133, avenue de la Résistance, 92350 Le Plessis-Robinson, France - Faculté de médecine, université Paris-Sud et université Paris-Saclay, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2018201DOI Listing
October 2018

Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.

Int J Clin Pharm 2018 Aug 13;40(4):790-794. Epub 2018 Aug 13.

INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11096-018-0712-yDOI Listing
August 2018

T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis.

Arthritis Res Ther 2018 08 29;20(1):197. Epub 2018 Aug 29.

Université Paris Descartes, Sorbonne Paris Cité, INSERM U1016, Institut Cochin, CNRS UMR8104, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-018-1694-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116494PMC
August 2018

Update in Pulmonary Vascular Disease 2016 and 2017.

Am J Respir Crit Care Med 2018 07;198(1):13-23

5 Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201801-0062UPDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034126PMC
July 2018

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era.

Eur Respir Rev 2018 Jun 13;27(148). Epub 2018 Apr 13.

Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0004-2018DOI Listing
June 2018

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad.

Eur Respir J 2018 06 21;51(6). Epub 2018 Jun 21.

Faculté de Médecine, Université Paris-Sud and Université Paris Saclay, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00848-2018DOI Listing
June 2018

Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.

Ann Rheum Dis 2017 Nov 11;76(11):1931-1940. Epub 2017 Aug 11.

Université Paris Descartes, Sorbonne Paris Cité, INSERM U1016, Institut Cochin, CNRS UMR8104, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-210821DOI Listing
November 2017

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.

Arthritis Rheumatol 2017 11 17;69(11):2209-2221. Epub 2017 Oct 17.

Université Paris Descartes, Sorbonne Paris Cité, INSERM U1016 and CNRS UMR8104, Institut Cochin, and Université Paris Descartes, Sorbonne Paris Cité, Service de Rhumatologie A, Hôpital Cochin, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40229DOI Listing
November 2017

Pathology and Pathobiology of Pulmonary Hypertension.

Semin Respir Crit Care Med 2017 10 15;38(5):571-584. Epub 2017 Oct 15.

INSERM UMR_S 999, "Pulmonary Hypertension: Physiopathology and Novel Therapies," Le Plessis-Robinson, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0037-1606214DOI Listing
October 2017

New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways.

Curr Opin Pulm Med 2017 09;23(5):377-385

aINSERM UMR_S 999, Le Plessis-Robinson bUniversity of Paris-Sud and Université Paris-Saclay, School of Medicine, DHU Thorax Innovation, Kremlin-Bicêtre cAP-HP, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, Hôpital de Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000404DOI Listing
September 2017

Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension".

Pulm Pharmacol Ther 2017 08 4;45:11-12. Epub 2017 Apr 4.

Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France; Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pupt.2017.03.017DOI Listing
August 2017

Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.

J Pharmacol Exp Ther 2017 Feb 7;360(2):267-279. Epub 2016 Dec 7.

Karos Pharmaceuticals, New Haven, Connecticut (R.J.A, P.-A.B, Q.Z, J.D., D.R.G., S.D.L., V.P.); INSERM UMR_S 999, Le Plessis-Robinson, France (M.H., C.G.), Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France (M.H., C.G.); Service de Pneumologie, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France (M.H.); Division of Cardiology and Consortium for Fibrosis Research and Translation, Department of Medicine, University of Colorado Denver, Aurora, Colorado (M.A.C., T.A.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.116.237933DOI Listing
February 2017

Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.

Expert Opin Ther Targets 2017 Feb 28;21(2):181-190. Epub 2016 Dec 28.

a INSERM UMR_S 999 , Le Plessis-Robinson , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2017.1275567DOI Listing
February 2017

[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].

Biol Aujourdhui 2016 30;210(2):65-78. Epub 2016 Sep 30.

INSERM UMRS 999, LabEx LERMIT, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis-Robinson, France - Université Paris-Sud, Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/jbio/2016010DOI Listing
January 2017

Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

Am J Physiol Heart Circ Physiol 2016 09 24;311(3):H604-12. Epub 2016 Jun 24.

Department of Pulmonology, VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00656.2015DOI Listing
September 2016

Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.

Chest 2016 06 21;149(6):1482-93. Epub 2016 Jan 21.

Inserm UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France; University of Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.01.004DOI Listing
June 2016

Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study.

Eur Respir J 2015 Oct 23;46(4):1211-4. Epub 2015 Jul 23.

Université Paris-Sud, Faculté de Pharmacie, Châtenay Malabry, France UMRS 999, INSERM et Univ. Paris-Sud, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France AP-HP, Service de Pharmacie, Département Hospitalo-Universitaire (DHU) Thorax Innovation, Hôpital Antoine Béclère, Clamart, France

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/content/erj/46/4/1211.full.pdf
Web Search
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.00051
Publisher Site
http://dx.doi.org/10.1183/13993003.00051-2015DOI Listing
October 2015

Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension.

Reprod Toxicol 2015 Aug 22;56:45-51. Epub 2015 Jun 22.

Pulmonary Hypertension Knowledge Center, Department of Pulmonology, VU University Medical Center/Institute for Cardiovascular Research, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reprotox.2015.06.048DOI Listing
August 2015

Leptin signalling system as a target for pulmonary arterial hypertension therapy.

Eur Respir J 2015 Apr 5;45(4):1066-80. Epub 2015 Mar 5.

INSERM UMR_S 999, Centre Chirurgical Marie Lannelongue, LabEx LERMIT, Le Plessis-Robinson, France Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/content/erj/45/4/1066.full.pdf
Web Search
http://erj.ersjournals.com/lookup/doi/10.1183/09031936.00193
Publisher Site
http://dx.doi.org/10.1183/09031936.00193014DOI Listing
April 2015

New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.

Chest 2015 Feb;147(2):529-537

INSERM UMR_S 999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; Univ. Paris-Sud, School of Medicine DHU Th orax Innovation, Kremlin-Biêtre; AP-HP Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital de Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.14-0862DOI Listing
February 2015

Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.

Histopathology 2014 Aug 19;65(2):278-82. Epub 2014 May 19.

Department of Pathology, Marie Lannelongue Surgical Centre, Le Plessis-Robinson, France; INSERM UMR 999, LabEx LERMIT, Marie Lannelongue Surgical Centre, Le Plessis-Robinson, France; School of Medicine, University Paris-Sud, Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12429DOI Listing
August 2014

Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertension.

Handb Exp Pharmacol 2013 ;218:409-36

INSERM UMR 999, "Pulmonary Hypertension: Physiopathology and Novel Therapies", LabEx LERMIT, Le Plessis-Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-38664-0_17DOI Listing
July 2014

Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension.

J Am Heart Assoc 2014 Jun 3;3(3):e000716. Epub 2014 Jun 3.

Department of Pulmonology, VU University Medical Center/Institute for Cardiovascular Research, Amsterdam, The Netherlands (S.R., D.S.G.B., N.W., H.J.B., A.V.N., F.S.M.) Department of Physiology, VU University Medical Center/Institute for Cardiovascular Research, Amsterdam, The Netherlands (S.R., L.H., N.W., G.S., C.O., M.G., J.V., F.S.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.113.000716DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309054PMC
June 2014

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats.

Respir Res 2014 Jun 14;15:65. Epub 2014 Jun 14.

UMRS 999, INSERM et Univ, Paris-Sud, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1465-9921-15-65DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065537PMC
June 2014

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Circ Res 2014 Jun;115(1):165-75

From the Cardiovascular Institute and Department of Pediatrics (M.R.) and Department of Medicine (M.R.N.), Stanford University School of Medicine, CA; INSERM UMR_S 999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson and Université Paris-Sud, School of Medicine, Le Kremlin-Bicêtre (C.G., M.H.); and AP-HP, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital de Bicêtre, France (M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.113.301141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097142PMC
June 2014

Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.

Circulation 2014 Apr 30;129(15):1586-97. Epub 2014 Jan 30.

National Institute of Health and Medical Research, Unit 999, LabEx Laboratory of Excellence in Research on Medication and Innovative Therapeutics, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France (N.R., L.T., M.L.H., A.H., C.P., R.T., C.S., E.F., A.S., D.M., P.D., M.H., C.G.); University Paris-Sud, School of Medicine, Kremlin-Bicêtre, France (N.R., L.T., M.L.H., A.H., C.P., R.T., C.S., E.F., A.S., D.M., P.D., M.H., C.G.); and Public Hospitals of Paris, Pneumology Service, Reference Center of Severe Pulmonary Hypertension, University Hospital Department Thorax Innovation, Hôpital de Bicêtre, Kremlin-Bicêtre, France (A.H., C.S., A.S., D.M., M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.007469DOI Listing
April 2014

Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay.

Circulation 2014 Mar;129(12):1332-40

Univ. Paris-Sud, Faculté de Médecine, Le Kremlin Bicêtre, F-94270 (A.H., F.P., L.T., S.C.-K., D.M., P.D., C.G., M.H.); AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, F-94270 (A.H., F.P., L.T., S.C.-K., D.M., P.D., C.G., M.H.); UMR_S 999, Univ. Paris-Sud; INSERM; Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, F-92350 (A.H., F.P., L.T., S.C.-K., D.M., P.D., C.G., M.H.), France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.004555DOI Listing
March 2014

Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.

Int J Cancer 2014 Feb 4;134(4):765-77. Epub 2013 Sep 4.

Service de Pneumologie, AP-HP, Hôpital Tenon, Paris, France; Equipe de Recherche 2, GRC UPMC-04, Université Paris 6 Pierre et Marie Curie, Service de Pneumologie, Hôpital Tenon, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28413DOI Listing
February 2014

Targeted therapies in pulmonary arterial hypertension.

Pharmacol Ther 2014 Feb 14;141(2):172-91. Epub 2013 Oct 14.

Univ. Paris-Sud, Le Kremlin-Bicêtre, France; AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; INSERM U999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2013.10.002DOI Listing
February 2014

Pathogenesis of pulmonary arterial hypertension: lessons from cancer.

Eur Respir Rev 2013 Dec;22(130):543-51

INSERM UMRS 999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, 2 Université Paris-Sud, Le Kremlin-Bicêtre, and 3 AP-HP, Service de Pneumologie, DHU Thorax Innovation (DHU TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09059180.00007513DOI Listing
December 2013

Relevant issues in the pathology and pathobiology of pulmonary hypertension.

J Am Coll Cardiol 2013 Dec;62(25 Suppl):D4-12

Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2013.10.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970402PMC
December 2013

Pathology and pathobiology of pulmonary hypertension.

Semin Respir Crit Care Med 2013 Oct 13;34(5):551-9. Epub 2013 Sep 13.

INSERM UMR_S 999, Cardiovascular Research Department, "Pulmonary Hypertension: Physiopathology and Novel Therapies," LabEx LERMIT, Le Plessis-Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0033-1356496DOI Listing
October 2013

Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?

Semin Respir Crit Care Med 2013 Oct 13;34(5):714-24. Epub 2013 Sep 13.

Pulmonary Section, Cliniques Universitaires de Mont-Godinne, University of Louvain, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0033-1356494DOI Listing
October 2013

Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.

Circulation 2013 Oct 20;128(18):2016-25, 1-10. Epub 2013 Sep 20.

Departments of Pulmonology (S.R., P.T., C.T.-J.G., N.W., P.E.P., A.V.-N., F.S.d.M.), Physiology (S.R., M.L.H., N.W., G.J.S., W.J.P., C.A.C.O., J.v.d.V., F.S.d.M.), Cardiology (M.L.H.), and Medical Physics (J.T.M.), VU University Medical Center/Institute for Cardiovascular Research, Amsterdam, the Netherlands; Université Paris-Sud, Le Kremlin-Bicêtre, France (P.D., C.G., M.H.); INSERM UMR 999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France (P.D., C.G., M.H.); AP-HP, Hôpital de Bicêtre, Service de Pneumologie, DHU Thorax Innovation, Le Kremlin-Bicêtre, France (M.H.); Heart & Lung Transplant Unit, St. Vincent's Hospital and Victor Chang Cardiac Research Institute, Sydney, Australia (P.M.); Muscle Research Unit, Institute for Biomedical Research, University of Sydney, Sydney, Australia (C.d.R.); Sarver Molecular Cardiovascular Research Program, Department of Physiology, University of Arizona, Tucson (C.S., C.G.H., H.L.G.); and ICIN-The Netherlands Heart Institute, Utrecht, the Netherlands (J.v.d.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.001873DOI Listing
October 2013

Cellular microparticles in the pathogenesis of pulmonary hypertension.

Eur Respir J 2013 Jul 20;42(1):272-9. Epub 2012 Dec 20.

INSERM U970, Paris Cardiovascular Research Center, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00087212DOI Listing
July 2013

Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?

Am J Respir Crit Care Med 2013 Jan 9;187(1):14-9. Epub 2012 Nov 9.

Department of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201209-1663PPDOI Listing
January 2013

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension.

Eur Respir J 2012 Oct 23;40(4):895-904. Epub 2012 Feb 23.

Universitaires Paris-Sud, Faculté de Médecine Le Kremlin-Bicêtre France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00159911DOI Listing
October 2012

Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.

FASEB J 2009 Dec 13;23(12):4135-47. Epub 2009 Aug 13.

INSERM Unity "Pulmonary Hypertension: Pathophysiology and Innovative Therapies," Centre Chirurgical Marie Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis-Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.09-131664DOI Listing
December 2009

RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.

Am J Respir Crit Care Med 2009 Jun 19;179(12):1151-8. Epub 2009 Mar 19.

INSERM U915, Faculté de médecine, 4 rue Gaston Veil, Nantes cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200805-691OCDOI Listing
June 2009

SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Development 2008 Sep 30;135(17):2981-91. Epub 2008 Jul 30.

Cardiopulmonary Research Program, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Stanford, California, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/dev.017863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653628PMC
September 2008

Developmental expression of LC3alpha and beta: absence of fibronectin or autophagy phenotype in LC3beta knockout mice.

Dev Dyn 2008 Jan;237(1):187-95

Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dvdy.21392DOI Listing
January 2008

Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.

Am J Pathol 2006 Nov;169(5):1624-32

Informatique, Biologie Intégrative et Systèmes Complexes, FRE 2873 Centre National de la Recherche Scientifique, Université d'Evry, Génopole, Evry, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000294401062627
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1780203PMC
http://dx.doi.org/10.2353/ajpath.2006.051053DOI Listing
November 2006